Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lewis, J. H.
Right arrow Articles by Escarce, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lewis, J. H.
Right arrow Articles by Escarce, J. J.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
Journal of Clinical Oncology, Vol 21, Issue 7 (April), 2003: 1383-1389
© 2003 American Society for Clinical Oncology

Participation of Patients 65 Years of Age or Older in Cancer Clinical Trials

Joy H. Lewis, Meredith L. Kilgore, Dana P. Goldman, Edward L. Trimble, Richard Kaplan, Michael J. Montello, Michael G. Housman, José J. Escarce

From RAND Health, Santa Monica; the University of California Los Angeles and the West Los Angeles Veterans Affairs Medical Center, Los Angeles, CA; and the National Institutes of Health, National Cancer Institute, Bethesda, MD.

Address reprint requests to Joy H. Lewis, DO, RAND, 1700 Main St, Santa Monica, CA 90407-2138; email: jhs{at}ucla.edu.

Purpose: Although 61% of new cases of cancer occur among the elderly, recent studies indicate that the elderly comprise only 25% of participants in cancer clinical trials. Further investigation into the reasons for low elderly participation is warranted. Our objective was to evaluate the participation of the elderly in clinical trials sponsored by the National Cancer Institute (NCI) and assess the impact of protocol exclusion criteria on elderly participation.

Patients and Methods: We conducted a retrospective analysis using NCI data, analyzing patient and trial characteristics for 59,300 patients enrolled onto 495 NCI-sponsored, cooperative group trials, active from 1997 through 2000. Our main outcome measure was the proportion of elderly patients enrolled onto cancer clinical trials compared with the proportion of incident cancer patients who are elderly.

Results: Overall, 32% of participants in phase II and III clinical trials were elderly, compared with 61% of patients with incident cancers in the United States who are elderly. The degree of underrepresentation was more pronounced in trials for early-stage cancers than in trials for late-stage cancers (P < .001). Furthermore, protocol exclusion criteria on the basis of organ-system abnormalities and functional status limitations were associated with lower elderly participation. We estimate that if protocol exclusions were relaxed, elderly participation in cancer trials would be 60%.

Conclusion: The elderly are underrepresented in cancer clinical trials relative to their disease burden. Older patients are more likely to have medical histories that make them ineligible for clinical trials because of protocol exclusions. Insurance coverage for clinical trials is one step toward improvement of elderly access to clinical trials. Without a change in study design or requirements, this step may not be sufficient.

Supported in part by the National Cancer Institute, with additional funding from the Office of the Director, National Institutes of Health, and the National Science Foundation. This research was also sponsored in part by the Robert Wood Johnson Clinical Scholars Program and by the Veterans Affairs (VA) Ambulatory Care Fellowship in Health Services Research at the West Los Angeles VA Medical Center (J.H.L.).

The opinions expressed in this article are solely those of the authors.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 JCOHome page
M. De Santis, J. Bellmunt, G. Mead, J. M. Kerst, M. Leahy, P. Maroto, I. Skoneczna, S. Marreaud, R. de Wit, and R. Sylvester
Randomized Phase II/III Trial Assessing Gemcitabine/ Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer "Unfit" for Cisplatin-Based Chemotherapy: Phase II--Results of EORTC Study 30986
J. Clin. Oncol., November 20, 2009; 27(33): 5634 - 5639.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
R. B. Hines, C. Chatla, H. L. Bumpers, J. W. Waterbor, G. McGwin Jr, E. Funkhouser, C. S. Coffey, J. Posey, and U. Manne
Predictive Capacity of Three Comorbidity Indices in Estimating Mortality After Surgery for Colon Cancer
J. Clin. Oncol., September 10, 2009; 27(26): 4339 - 4345.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
H. B. Muss, D. A. Berry, C. T. Cirrincione, M. Theodoulou, A. M. Mauer, A. B. Kornblith, A. H. Partridge, L. G. Dressler, H. J. Cohen, H. P. Becker, et al.
Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer
N. Engl. J. Med., May 14, 2009; 360(20): 2055 - 2065.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
D. W. Rasco, Y. Xie, J. Yan, J. R. Sayne, C. S. Skinner, J. E. Dowell, and D. E. Gerber
The Impact of Consenter Characteristics and Experience on Patient Interest in Clinical Research
Oncologist, May 1, 2009; 14(5): 468 - 475.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
S. S. Ramalingam and F. R. Khuri
The Role of the Taxanes in the Treatment of Older Patients with Advanced Stage Non-Small Cell Lung Cancer
Oncologist, April 1, 2009; 14(4): 412 - 424.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
M. Pellegrinotti, F. L. Fimognari, A. Franco, L. Repetto, and R. Pastorelli
Erlotinib-Induced Hepatitis Complicated by Fatal Lactic Acidosis in an Elderly Man With Lung Cancer
Ann. Pharmacother., March 1, 2009; 43(3): 542 - 545.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
G. Beadle, P. Baade, and L. Fritschi
Acute myeloid leukemia after breast cancer: a population-based comparison with hematological malignancies and other cancers
Ann. Onc., January 1, 2009; 20(1): 103 - 109.
[Abstract] [Full Text] [PDF]

Home page
 Am Soc Clin Oncol Ed BookHome page
C. Gridelli, P. Maione, and A. Rossi
Chemotherapy and Targeted Therapy for Older Patients with Advanced Non-small Cell Lung Cancer
ASCO Educational Book, January 1, 2009; 2009(1): 283 - 287.
[Abstract] [Full Text] [PDF]

Home page
 Am Soc Clin Oncol Ed BookHome page
M. Extermann and H. B. Muss
Conducting Clinical Trials for Patients Who Are Frail or Elderly
ASCO Educational Book, January 1, 2009; 2009(1): 289 - 293.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. Hurria, F. L. Wong, D. Villaluna, S. Bhatia, C. T. Chung, J. Mortimer, S. Hurvitz, and A. Naeim
Role of Age and Health in Treatment Recommendations for Older Adults With Breast Cancer: The Perspective of Oncologists and Primary Care Providers
J. Clin. Oncol., November 20, 2008; 26(33): 5386 - 5392.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
I. Biasoli, P. Franchi-Rezgui, D. Sibon, J. Briere, E. de Kerviler, C. Thieblemont, V. Levy, C. Gisselbrecht, and P. Brice
Analysis of factors influencing inclusion of 102 patients with stage III/IV Hodgkin's lymphoma in a randomized trial for first-line chemotherapy
Ann. Onc., November 1, 2008; 19(11): 1915 - 1920.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. Lemieux, P. J. Goodwin, K. I. Pritchard, K. A. Gelmon, L. J. Bordeleau, T. Duchesne, S. Camden, and C. H. Speers
Identification of Cancer Care and Protocol Characteristics Associated With Recruitment in Breast Cancer Clinical Trials
J. Clin. Oncol., September 20, 2008; 26(27): 4458 - 4465.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. R. Baquet, G. L. Ellison, and S. I. Mishra
Analysis of Maryland Cancer Patient Participation in National Cancer Institute-Supported Cancer Treatment Clinical Trials
J. Clin. Oncol., July 10, 2008; 26(20): 3380 - 3386.
[Abstract] [Full Text] [PDF]

Home page
 J Oncol PractHome page
M. Basche, A. E. Baron, S. G. Eckhardt, L. Balducci, M. Persky, A. Levin, N. Jackson, C. Zeng, P. Vranas, and J. F. Steiner
Barriers to Enrollment of Elderly Adults in Early-Phase Cancer Clinical Trials
J. Oncol. Pract, July 1, 2008; 4(4): 162 - 168.
[Abstract] [Full Text] [PDF]

Home page
 Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
V. Girre, M.-C. Falcou, M. Gisselbrecht, G. Gridel, V. Mosseri, C. Bouleuc, R. Poinsot, L. Vedrine, L. Ollivier, V. Garabige, et al.
Does a Geriatric Oncology Consultation Modify the Cancer Treatment Plan for Elderly Patients?
J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2008; 63(7): 724 - 730.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
P. Wheatley-Price, K. Ding, L. Seymour, G. M. Clark, and F. A. Shepherd
Erlotinib for Advanced Non-Small-Cell Lung Cancer in the Elderly: An Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21
J. Clin. Oncol., May 10, 2008; 26(14): 2350 - 2357.
[Abstract] [Full Text] [PDF]

Home page
 haematolHome page
D. Pulte, A. Gondos, and H. Brenner
Improvements in survival of adults diagnosed with acute myeloblastic leukemia in the early 21st century
Haematologica, April 1, 2008; 93(4): 594 - 600.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
C.-H. Kohne, G. Folprecht, R. M. Goldberg, E. Mitry, and P. Rougier
Chemotherapy in Elderly Patients with Colorectal Cancer
Oncologist, April 1, 2008; 13(4): 390 - 402.
[Abstract] [Full Text] [PDF]

Home page
 Am Soc Clin Oncol Ed BookHome page
J. R. Lange and C. M. Balch
Melanoma in Older Patients
ASCO Educational Book, January 1, 2008; 2008(1): 399 - 402.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
L. Balducci, H. Al-Halawani, V. Charu, J. Tam, S. Shahin, L. Dreiling, and W. B. Ershler
Elderly Cancer Patients Receiving Chemotherapy Benefit from First-Cycle Pegfilgrastim
Oncologist, December 1, 2007; 12(12): 1416 - 1424.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
E. B. Elkin, S. H.M. Kim, E. S. Casper, D. W. Kissane, and D. Schrag
Desire for Information and Involvement in Treatment Decisions: Elderly Cancer Patients' Preferences and Their Physicians' Perceptions
J. Clin. Oncol., November 20, 2007; 25(33): 5275 - 5280.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. C. Pinder, Z. Duan, J. S. Goodwin, G. N. Hortobagyi, and S. H. Giordano
Congestive Heart Failure in Older Women Treated With Adjuvant Anthracycline Chemotherapy for Breast Cancer
J. Clin. Oncol., September 1, 2007; 25(25): 3808 - 3815.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. W. Gray, F. J. Hlubocky, M. J. Ratain, and C. K. Daugherty
Attitudes Toward Research Participation and Investigator Conflicts of Interest Among Advanced Cancer Patients Participating in Early Phase Clinical Trials
J. Clin. Oncol., August 10, 2007; 25(23): 3488 - 3494.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
A Gondos, B Holleczek, V Arndt, C Stegmaier, H Ziegler, and H Brenner
Trends in population-based cancer survival in Germany: to what extent does progress reach older patients?
Ann. Onc., July 1, 2007; 18(7): 1253 - 1259.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. D. Wagner, U. Wedding, O. Kuss, and K. Hoffken
Docetaxel for Advanced Gastric Cancer?
J. Clin. Oncol., June 10, 2007; 25(17): 2490 - 2491.
[Full Text] [PDF]

Home page
 JCOHome page
C. Bouchardy, E. Rapiti, S. Blagojevic, A.-T. Vlastos, and G. Vlastos
Older Female Cancer Patients: Importance, Causes, and Consequences of Undertreatment
J. Clin. Oncol., May 10, 2007; 25(14): 1858 - 1869.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
H. B. Muss, L. Biganzoli, D. J. Sargent, and M. Aapro
Adjuvant Therapy in the Elderly: Making the Right Decision
J. Clin. Oncol., May 10, 2007; 25(14): 1870 - 1875.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. Terret, G. B. Zulian, A. Naiem, and G. Albrand
Multidisciplinary Approach to the Geriatric Oncology Patient
J. Clin. Oncol., May 10, 2007; 25(14): 1876 - 1881.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. Gridelli, C. Langer, P. Maione, A. Rossi, and S. E. Schild
Lung Cancer in the Elderly
J. Clin. Oncol., May 10, 2007; 25(14): 1898 - 1907.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J.-C. Horiot
Radiation Therapy and the Geriatric Oncology Patient
J. Clin. Oncol., May 10, 2007; 25(14): 1930 - 1935.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
I. Jatoi, B. E. Chen, W. F. Anderson, and P. S. Rosenberg
Breast Cancer Mortality Trends in the United States According to Estrogen Receptor Status and Age at Diagnosis
J. Clin. Oncol., May 1, 2007; 25(13): 1683 - 1690.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
L. L. Siu
Clinical Trials in the Elderly -- A Concept Comes of Age
N. Engl. J. Med., April 12, 2007; 356(15): 1575 - 1576.
[Full Text] [PDF]

Home page
 JCOHome page
A. Kumar, H. P. Soares, L. Balducci, and B. Djulbegovic
Treatment Tolerance and Efficacy in Geriatric Oncology: A Systematic Review of Phase III Randomized Trials Conducted by Five National Cancer Institute-Sponsored Cooperative Groups
J. Clin. Oncol., April 1, 2007; 25(10): 1272 - 1276.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. J. Langer
Mind Your Elders: Therapeutic Implications of Epidermal Growth Factor Receptor Inhibition in Older Patients With Advanced Non-Small-Cell Lung Cancer
J. Clin. Oncol., March 1, 2007; 25(7): 751 - 753.
[Full Text] [PDF]

Home page
 Ann OncolHome page
F Hilpert, A du Bois, E. Greimel, J Hedderich, G Krause, L Venhoff, S Loibl, and J Pfisterer
Feasibility, toxicity and quality of life of first-line chemotherapy with platinum/paclitaxel in elderly patients aged >=70 years with advanced ovarian cancer--a study by the AGO OVAR Germany
Ann. Onc., February 1, 2007; 18(2): 282 - 287.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
O Tredan, J-F Geay, S Touzet, R Delva, B Weber, J Cretin, J Provencal, J Martin, L Stefani, E Pujade-Lauraine, et al.
Carboplatin/cyclophosphamide or carboplatin/paclitaxel in elderly patients with advanced ovarian cancer? Analysis of two consecutive trials from the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens
Ann. Onc., February 1, 2007; 18(2): 256 - 262.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
P Zola and A Ferrero
Is carboplatin-paclitaxel combination the standard treatment of elderly ovarian cancer patients?
Ann. Onc., February 1, 2007; 18(2): 213 - 214.
[Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
E. B. Lamont, J. E. Herndon II, J. C. Weeks, I. C. Henderson, C. C. Earle, R. L. Schilsky, and N. A. Christakis
Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344).
J Natl Cancer Inst, September 20, 2006; 98(18): 1335 - 1338.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
B. M. Ford, J. S. Evans, E. M. Stoffel, J. Balmana, M. M. Regan, and S. Syngal
Factors associated with enrollment in cancer genetics research.
Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1355 - 1359.
[Abstract] [Full Text] [PDF]

Home page
 Clin TrialsHome page
G. Y Lai, T. L Gary, J. Tilburt, S. Bolen, C. Baffi, R. F Wilson, M. W Howerton, M C. Gibbons, T. P. Tanpitukpongse, N. R Powe, et al.
Effectiveness of strategies to recruit underrepresented populations into cancer clinical trials
Clinical Trials, April 1, 2006; 3(2): 133 - 141.
[Abstract] [PDF]

Home page
 Clin. Cancer Res.Home page
E. L. Trimble and M. C. Christian
Cancer treatment and the older patient.
Clin. Cancer Res., April 1, 2006; 12(7): 1956 - 1957.
[Full Text] [PDF]

Home page
 Ann OncolHome page
P. Harter, A. du Bois, C. Schade-Brittinger, A. Burges, K. Wollschlaeger, M. Gropp, B. Schmalfeldt, J. Huober, A. Staehle, J. Pfisterer, et al.
Non-enrolment of ovarian cancer patients in clinical trials: reasons and background
Ann. Onc., November 1, 2005; 16(11): 1801 - 1805.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. M. Geraci, C. P. Escalante, J. L. Freeman, and J. S. Goodwin
Comorbid Disease and Cancer: The Need for More Relevant Conceptual Models in Health Services Research
J. Clin. Oncol., October 20, 2005; 23(30): 7399 - 7404.
[Full Text] [PDF]

Home page
 ChestHome page
C. Gridelli and F. A. Shepherd
Chemotherapy for Elderly Patients With Non-Small Cell Lung Cancer: A Review of the Evidence
Chest, August 1, 2005; 128(2): 947 - 957.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. P. Gross, J. Herrin, N. Wong, and H. M. Krumholz
Enrolling Older Persons in Cancer Trials: The Effect of Sociodemographic, Protocol, and Recruitment Center Characteristics
J. Clin. Oncol., July 20, 2005; 23(21): 4755 - 4763.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
E. B. Lamont, J. E. Herndon II, J. C. Weeks, I. C. Henderson, R. Lilenbaum, R. L. Schilsky, N. A. Christakis, and for the Cancer and Leukemia Group B
Criterion Validity of Medicare Chemotherapy Claims in Cancer and Leukemia Group B Breast and Lung Cancer Trial Participants
J Natl Cancer Inst, July 20, 2005; 97(14): 1080 - 1083.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
C. P. Gross, N. Wong, J. A. Dubin, S. T. Mayne, and H. M. Krumholz
Enrollment of Older Persons in Cancer Trials After the Medicare Reimbursement Policy Change
Arch Intern Med, July 11, 2005; 165(13): 1514 - 1520.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. Townsley, G. R. Pond, B. Peloza, J. Kok, K. Naidoo, D. Dale, C. Herbert, E. Holowaty, S. Straus, and L. L. Siu
Analysis of Treatment Practices for Elderly Cancer Patients in Ontario, Canada
J. Clin. Oncol., June 1, 2005; 23(16): 3802 - 3810.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C.P. Gross and H.M. Krumholz
Impact of Managed Care on Cancer Trial Enrollment
J. Clin. Oncol., June 1, 2005; 23(16): 3811 - 3818.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
A. Rossi, P. Maione, G. Colantuoni, C. Guerriero, C. Ferrara, F. Del Gaizo, D. Nicolella, and C. Gridelli
Treatment of Small Cell Lung Cancer in the Elderly
Oncologist, June 1, 2005; 10(6): 399 - 411.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. Feliu, P. Escudero, F. Llosa, M. Bolanos, J.-M. Vicent, A. Yubero, J.-J. Sanz-Lacalle, R. Lopez, L. Lopez-Gomez, E. Casado, et al.
Capecitabine As First-Line Treatment for Patients Older Than 70 Years With Metastatic Colorectal Cancer: An Oncopaz Cooperative Group Study
J. Clin. Oncol., May 1, 2005; 23(13): 3104 - 3111.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. A. Townsley, R. Selby, and L. L. Siu
Systematic Review of Barriers to the Recruitment of Older Patients With Cancer Onto Clinical Trials
J. Clin. Oncol., May 1, 2005; 23(13): 3112 - 3124.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. Gridelli, M. Aapro, A. Ardizzoni, L. Balducci, F. De Marinis, K. Kelly, T. Le Chevalier, C. Manegold, F. Perrone, R. Rosell, et al.
Treatment of Advanced Non-Small-Cell Lung Cancer in the Elderly: Results of an International Expert Panel
J. Clin. Oncol., May 1, 2005; 23(13): 3125 - 3137.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
G. G. Kimmick, B. L. Peterson, A. B. Kornblith, J. Mandelblatt, J. L. Johnson, J. Wheeler, R. Heinze, H. J. Cohen, and H. B. Muss
Improving Accrual of Older Persons to Cancer Treatment Trials: A Randomized Trial Comparing an Educational Intervention With Standard Information: CALGB 360001
J. Clin. Oncol., April 1, 2005; 23(10): 2201 - 2207.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
M. S. Aapro, C.-H. Kohne, H. J. Cohen, and M. Extermann
Never Too Old? Age Should Not Be a Barrier to Enrollment in Cancer Clinical Trials
Oncologist, March 1, 2005; 10(3): 198 - 204.
[Abstract] [Full Text] [PDF]

Home page
 ASH Education BookHome page
R. A. Larson
Acute Lymphoblastic Leukemia: Older Patients and Newer Drugs
Hematology, January 1, 2005; 2005(1): 131 - 136.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
L. Talarico, G. Chen, and R. Pazdur
Enrollment of Elderly Patients in Clinical Trials for Cancer Drug Registration: A 7-Year Experience by the US Food and Drug Administration
J. Clin. Oncol., November 15, 2004; 22(22): 4626 - 4631.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. R. Wright, T. J. Whelan, S. Schiff, S. Dubois, D. Crooks, P. T. Haines, D. DeRosa, R. S. Roberts, A. Gafni, K. Pritchard, et al.
Why Cancer Patients Enter Randomized Clinical Trials: Exploring the Factors That Influence Their Decision
J. Clin. Oncol., November 1, 2004; 22(21): 4312 - 4318.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
G. Folprecht, D. Cunningham, P. Ross, B. Glimelius, F. Di Costanzo, J. Wils, W. Scheithauer, P. Rougier, E. Aranda, H. Hecker, et al.
Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials
Ann. Onc., September 1, 2004; 15(9): 1330 - 1338.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
H. Minami, Y. Ohe, S. Niho, K. Goto, H. Ohmatsu, K. Kubota, R. Kakinuma, Y. Nishiwaki, H. Nokihara, I. Sekine, et al.
Comparison of Pharmacokinetics and Pharmacodynamics of Docetaxel and Cisplatin in Elderly and Non-Elderly Patients: Why Is Toxicity Increased in Elderly Patients?
J. Clin. Oncol., July 15, 2004; 22(14): 2901 - 2908.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
V. H. Murthy, H. M. Krumholz, and C. P. Gross
Participation in Cancer Clinical Trials: Race-, Sex-, and Age-Based Disparities
JAMA, June 9, 2004; 291(22): 2720 - 2726.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
C. Gridelli, A. Ardizzoni, T. Le Chevalier, C. Manegold, F. Perrone, N. Thatcher, N. van Zandwijk, M. Di Maio, O. Martelli, and F. De Marinis
Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts Panel
Ann. Onc., March 1, 2004; 15(3): 419 - 426.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. Argiris, Y. Li, B. A. Murphy, C. J. Langer, and A. A. Forastiere
Outcome of Elderly Patients With Recurrent or Metastatic Head and Neck Cancer Treated With Cisplatin-Based Chemotherapy
J. Clin. Oncol., January 15, 2004; 22(2): 262 - 268.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. A. Townsley, K. Naidoo, G. R. Pond, W. Melnick, S. E. Straus, and L. L. Siu
Are Older Cancer Patients Being Referred to Oncologists? A Mail Questionnaire of Ontario Primary Care Practitioners to Evaluate Their Referral Patterns
J. Clin. Oncol., December 15, 2003; 21(24): 4627 - 4635.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
R. A. Silliman
What Constitutes Optimal Care for Older Women With Breast Cancer?
J. Clin. Oncol., October 1, 2003; 21(19): 3554 - 3556.
[Full Text] [PDF]

Home page
 NEJMHome page
J. L. Kaufman, B. T. Bateman, P. M. Meyers, H. C. Schumacher, J. T. Berger, J. H.T. Karlawish, D. J. Campbell, A. Karnad, J. Sudbo, F. G. Miller, et al.
Protection of Research Subjects
N. Engl. J. Med., July 10, 2003; 349(2): 188 - 192.
[Full Text] [PDF]


About
JCO		 Editorial
Roster		 Advertising
Information		 Librarians &
Institutions		 Rights &
Permissions		 PDA Services

Copyright © 2003 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online